Why Morphic Therapeutic (MORF) Stock Leapt More Than 100% Today? Here Is The Reason
The stock of biopharmaceutical company Morphic Therapeutic (Nasdaq: MORF) has been trading at an uptick of +104.98% to $74.12 in early trading today (10:55 a.m. EST). The price rise came following an announcement of positive results of an ongoing clinical study for the treatment of inflammatory bowel disease (IBD). Get the hottest stocks to trade […]
Insider Selling: Morphic Holding Inc. [MORF] Pres, CEO Sells 8,000 Shares Worth $256,781
On Jan. 04, Tipirneni Praveen P. divested U.S. $256,781 in shares of Morphic Holding Inc.. The Pres, CEO sold 8,000 shares at a price per share of $32.10. The transaction decreased this specific insider’s holdings to 630,287 shares worth around $18.77 million at present. Another 37,641 shares were sold by Rogers Bruce, for more than […]
